Alzheimer’s Disease Updates for Northern Michigan Caregivers
Because we are considered to be northern Michigan’s aging services experts, we maintain a strong commitment to on-going community education. One important senior-related issue we closely follow is the progress of research on Alzheimer’s disease and the latest clinical trials and treatment studies. While a cure remains elusive, there is reason to hope. We thought our readers would be interested in learning about some of the on-going trials across the country.
- National Resveratrol Study for Alzheimer’s Disease at Georgetown University – Highly regarded for their cutting edge, innovative research, The Memory Disorder program at Georgetown University Medical Center is in Phase II of this important trial. Scientists at Georgetown are investigating the role resveratrol may play in Alzheimer’s disease. Resveratrol is found in grapes, chocolate, tomatoes, peanuts and red wine.
- Cholesterol and Alzheimer’s: A Big Step Forward – Cholesterol and its link to Alzheimer’s disease have long been a topic of discussion. Read a quick overview here or the full abstract in The Journal of Neuroscience.
- Alzheimer’s Pacemaker Trials – In December of 2012, surgeons at The Johns Hopkins University Medical Center implanted pacemakers in two people with early-onset Alzheimer’s. By the end of 2013, Johns Hopkins and four other major medical centers will have performed this same surgery on an additional 40 patients. Early indications from a smaller study leading up to this seemed to indicate that a pacemaker could help to increase glucose metabolism. That indicator of neuronal activity usually decreases as Alzheimer’s disease follows its normal course. Sign up to follow our blog for updates or follow the team at Johns Hopkins to learn more.
- Glucose Levels and Risk of Dementia – This study was published in August in The New England Journal of Medicine. It shared the results of a trial that explored the effect increased glucose levels and diabetes might have on dementia. The study showed that higher glucose rates for even non-diabetics can increase the chance of developing dementia.
- Salk scientists develop drug that slows Alzheimer’s in mice –A drug developed by scientists at the Salk Institute for Biological Studies was the focus of an article published in the May issue of Alzheimer’s Research and Therapy. Known as J147, the drug has been shown to reverse memory deficits and slow the progression of Alzheimer’s disease in aged mice following short-term treatment. Salk Institute is currently recruiting patients for the next phase of their work.
If you are interested in staying updated on the latest research on Alzheimer’s disease and other aging services issues, subscribe to our blog. You can also “Like” us on Facebook where we share information and updates with our friends on a regular basis.